IndraLab

Statements


| 2

reach
"Moreover, Butyric acid has been demonstrated to reduce systemic inflammation by inhibiting the STAT1/AP1 signaling pathways in peritoneal macrophages, as well as the presence of NLRP3 inflammasomes and pro-inflammatory factors [103]."
| PMC

reach
"Butyric acid was also demonstrated to effectively inhibit STAT1 activation by reducing IFN-gamma production, which results in the apoptosis of T cells of unspecified type and the suppression of the inflammation [XREF_BIBR]."